Hydrogen sulfide treatment mitigates renal allograft ischemia-reperfusion injury during cold storage and improves early transplant kidney function and survival following allogeneic renal transplantation

Journal of Urology

Volumn 194, Issue 6, 2015, Pages 1806-1815

  Lobb, Ian ^a   Davison, Michael ^a   Carter, David ^a   Liu, Weihua ^a   Haig, Aaron ^a   Gunaratnam, Lakshman ^a   Sener, Alp ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

graft survival; hydrogen sulfide; kidney transplantation; reperfusion injury; transcriptome

Indexed keywords

ALLOANTIBODY; HYDROGEN SULFIDE; TRANSCRIPTOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELLULAR STRESS RESPONSE; COLD ISCHEMIA; COMPARATIVE STUDY; CONTROLLED STUDY; CRYOPRESERVATION; FEMALE; GRAFT SURVIVAL; KIDNEY ALLOGRAFT; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY ISCHEMIA; KIDNEY PRESERVATION; MALE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SURVIVAL RATE; THROMBOCYTE AGGREGATION; TISSUE REGENERATION; URINALYSIS; URINE VOLUME; ALLOGRAFT; ANIMAL; BROWN NORWAY RAT; CELL SURVIVAL; DISEASE MODEL; DRUG EFFECTS; KAPLAN MEIER METHOD; KIDNEY TRANSPLANTATION; LEWIS RAT; ORGAN PRESERVATION; PATHOLOGY; PRIMARY GRAFT DYSFUNCTION; PROCEDURES; TUMOR CELL LINE;

ALLOGRAFTS; ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; COLD ISCHEMIA; DISEASE MODELS, ANIMAL; GRAFT SURVIVAL; HYDROGEN SULFIDE; KAPLAN-MEIER ESTIMATE; KIDNEY TRANSPLANTATION; MALE; ORGAN PRESERVATION; PRIMARY GRAFT DYSFUNCTION; RATS; RATS, INBRED BN; RATS, INBRED LEW; REPERFUSION INJURY; TRANSCRIPTOME;

EID: 84947243224     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2015.07.096     Document Type: Article

References (27)

1. M.J. Wilhelm, J. Pratschke, I. Laskowski, and et al. Ischemia and reperfusion injury Transplant Rev 17 2003 140
2. A.K. Salahudeen, N. Haider, and W. May Cold ischemia and the reduced long-term survival of cadaveric renal allografts Kidney Int 65 2004 713
3. I. Quiroga, P. McShane, D.D. Koo, and et al. Major effects of delayed graft function and cold ischaemia time on renal allograft survival Nephrol Dial Transplant 21 2006 1689
4. B.F. Moody, and J.W. Calvert Emergent role of gasotransmitters in ischemia-reperfusion injury Med Gas Res 1 2011 3
5. R. Wang Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter? FASEB J 16 2002 1792
6. L. Li, P. Rose, and P.K. Moore Hydrogen sulfide and cell signaling Annu Rev Pharmacol Toxicol 51 2011 169
7. I. Lobb, E. Sonke, G. Aboalsamh, and et al. Hydrogen sulphide and the kidney: Important roles in renal physiology and pathogenesis and treatment of kidney injury and disease Nitric Oxide 46 2014 55
8. P.M. Snijder, E. van den Berg, M. Whiteman, and et al. Emerging role of gasotransmitters in renal transplantation Am J Transplant 13 2013 3067
9. I. Lobb, A. Mok, Z. Lan, and et al. Supplemental hydrogen sulphide protects transplant kidney function and prolongs recipient survival after prolonged cold ischaemia-reperfusion injury by mitigating renal graft apoptosis and inflammation BJU Int 110 2012 E1187
10. Z. Lan, W. Ge, J. Arp, and et al. Induction of kidney allograft tolerance by soluble CD83 associated with prevalence of tolerogenic dendritic cells and indoleamine 2,3-dioxygenase Transplantation 90 2010 1286
11. R.A. Irizarry, B.M. Bolstad, F. Collin, and et al. Summaries of Affymetrix GeneChip probe level data Nucleic Acids Res 31 2003 e15
12. R. Wang Gasotransmitters: growing pains and joys Trends Biochem Sci 39 2014 227
13. A. Sivarajah, M. Collino, M. Yasin, and et al. Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I/R Shock 31 2009 267
14. J.X. Zhu, M. Kalbfleisch, Y.X. Yang, and et al. Detrimental effects of prolonged warm renal ischaemia-reperfusion injury are abrogated by supplemental hydrogen sulphide: an analysis using real-time intravital microscopy and polymerase chain reaction BJU Int 110 2012 E1218
15. J.V. Bonventre Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more Nephrol Dial Transplant 24 2009 3265
16. O. Liangos, M.C. Perianayagam, V.S. Vaidya, and et al. Urinary N-acetyl-beta-(D)-glucosaminidase activity-under1 and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure J Am Soc Nephrol 18 2007 904
17. I.E. Hall, S.G. Yarlagadda, S.G. Coca, and et al. IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation J Am Soc Nephrol 21 2010 189
18. P.F. Halloran, L.W. Miller, J. Urmson, and et al. IFN-gamma alters the pathology of graft rejection: protection from early necrosis J Immunol 166 2001 7072
19. P.F. Halloran, M. Afrouzian, V. Ramassar, and et al. Interferon-gamma acts directly on rejecting renal allografts to prevent graft necrosis Am J Pathol 158 2001 215
20. M. Afrouzian, V. Ramassar, J. Urmson, and et al. Transcription factor IRF-1 in kidney transplants mediates resistance to graft necrosis during rejection J Am Soc Nephrol 13 2002 1199
21. R. Baskar, and J. Bian Hydrogen sulfide gas has cell growth regulatory role Eur J Pharmacol 656 2011 5
22. J.L. Wallace, M. Dicay, W. McKnight, and et al. Hydrogen sulfide enhances ulcer healing in rats FASEB J 21 2007 4070
23. A. Papapetropoulos, A. Pyriochou, Z. Altaany, and et al. Hydrogen sulfide is an endogenous stimulator of angiogenesis Proc Natl Acad Sci U S A 106 2009 21972
24. Y. Shen, W. Guo, Z. Wang, and et al. Protective effects of hydrogen sulfide in hypoxic human umbilical vein endothelial cells: a possible mitochondria-dependent pathway Int J Mol Sci 14 2013 13093
25. J.C. Reynolds, L.Y. Agodoa, C.M. Yuan, and et al. Thrombotic microangiopathy after renal transplantation in the United States Am J Kidney Dis 42 2003 1058
26. L. Gao, C. Cheng, A. Sparatore, and et al. Hydrogen sulfide inhibits human platelet aggregation in vitro in part by interfering gap junction channels: effects of ACS14, a hydrogen sulfide-releasing aspirin Heart Lung Circ 24 2015 77
27. L. Zhong, L. Lv, J. Yang, and et al. Inhibitory effect of hydrogen sulfide on platelet aggregation and the underlying mechanisms J Cardiovasc Pharmacol 64 2014 481